Tumor Necrosis Factor Inhibitors Provide Longterm Clinical Benefits in Pediatric and Young Adult Patients with Blau Syndrome.
| Autor: | TOMOKAZU NAGAKURA, HIROYUKI WAKIGUCHI, TOMOHIRO KUBOTA, TSUYOSHI YAMATOU, YUICHI YAMASAKI, YUKIKO NONAKA, YASUHITO NEROME, HARUMI AKAIKE, TOMOKO TAKEZAKI, HIROYUKI IMANAKA, YOSHIFUMI KAWANO, SYUJI TAKEI, Nagakura, Tomokazu, Wakiguchi, Hiroyuki, Kubota, Tomohiro, Yamatou, Tsuyoshi, Yamasaki, Yuichi, Nonaka, Yukiko, Nerome, Yasuhito, Akaike, Harumi |
|---|---|
| Zdroj: | Journal of Rheumatology; Apr2017, Vol. 44 Issue 4, p536-538, 3p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|